Published in Rev Med Suisse Romande on November 01, 1968
Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest (1969) 3.16
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man. J Clin Endocrinol Metab (1992) 1.31
Effect of insulin in vivo on diaphragm and adipose tissue of obese mice. Am J Physiol (1969) 1.17
[Ultrastructural events associated with the action of tolbutamide and glybenclamide on pancreatic B-cells in vivo and in vitro]. Acta Diabetol Lat (1969) 1.17
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res (1989) 1.09
Insulin and glucagon release from monolayer cell cultures of pancreas from newborn rats. Eur J Clin Invest (1973) 1.07
Asymptomatic bacteriuria in diabetes mellitus. N Engl J Med (1967) 1.05
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci U S A (1988) 1.00
Spontaneous hyperglycemia and-or obesity in laboratory rodents: an example of the possible usefulness of animal disease models with both genetic and environmental components. Recent Prog Horm Res (1971) 0.97
Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes (1990) 0.96
Adrenergic modification of glucose-induced biphasic insulin release from perifused rat pancreas. Eur J Clin Invest (1971) 0.96
Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia (1981) 0.95
Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis. Arterioscler Thromb (1991) 0.94
Dynamic aspects of proinsulin release from perifused rat pancreas. Lancet (1969) 0.92
Role of glucagon in enhancing ketone body production in ketotic diabetic man. Diabetes (1983) 0.91
On the role of cyclic AMP in insulin release: II. Dynamic aspects and relations to adrenergic receptors in the perfused pancreas of adult rats. Ann N Y Acad Sci (1971) 0.91
Perifusion of rat pancreatic tissue in vitro: substrate modification of theophylline-induced biphasic insulin release. J Clin Invest (1970) 0.91
Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. J Lipid Res (1988) 0.90
Streptozotocin diabetes: time course of irreversible B-cell damage; further observations on prevention by nicotinamide. Proc Soc Exp Biol Med (1970) 0.90
Acid phosphatase activity in secretory granules of pancreatic beta cells of normal rats. Diabetes (1971) 0.89
Defective immunoreative insulin secretion in the Acomys cahirinus. Diabetes (1972) 0.87
Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas. J Clin Invest (1971) 0.87
The kidney of spiny mice (Acomys cahirinus): electron microscopy of glomerular changes associated with ageing and tubular glycogen accumulation during hyperglycemia. Diabetologia (1970) 0.87
Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulin-deficient man. Diabetologia (1984) 0.85
Effect of insulin on ketone body clearance studied by a ketone body "clamp" technique in normal man. Diabetologia (1988) 0.85
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen. Int J Clin Pharmacol Biopharm (1979) 0.85
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
Metabolic consequences of portacaval shunting in the rat: effects on glucose tolerance and serum immunoreactive insulin response. Metabolism (1971) 0.85
An ultrastructural study of the islet cell tumor of the golden hamster. Horm Metab Res (1971) 0.85
Stimulatory effect of norepinephrine on ketogenesis in normal and insulin-deficient humans. Am J Physiol (1984) 0.85
Metabolic state, pancreatic insulin content and B-cell morphology of normoglycemie spiny mice (Acomys cahirinus): indications for an impairment of insulin secretion. Diabetologia (1970) 0.85
Obesity and diabetes mellitus with striking congenital hyperplasia of the islets of langerhans in spiny mice (Acomys Cahirinus) : I. Histological findings and preliminary metabolic observations. Diabetologia (1966) 0.84
Studies in spiny mice (Acomys cahirinus): metabolic state and pancreatic insulin release in vitro. Horm Metab Res (1969) 0.83
Kinetics of immunoreactive insulin in obese hyperglycemic laboratory rodents. Endocrinology (1973) 0.83
[Regulation of insulin release in perifused pancreatic tissue]. Acta Diabetol Lat (1969) 0.83
[The autonomous nervous system and the B-cell: metabolic and morphological observations made in spiny mice (Acomys cahirinus) and in cultured fetal rat pancreas]. Acta Diabetol Lat (1970) 0.83
Effects of endotoxin on leucine and glucose kinetics in man: contribution of prostaglandin E2 assessed by a cyclooxygenase inhibitor. J Clin Endocrinol Metab (1993) 0.83
Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia (1995) 0.83
Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man. Diabetes (1984) 0.83
Role of the splanchnic bed in extracting circulating adrenaline and noradrenaline in normal subjects and in patients with cirrhosis of the liver. Clin Sci (Lond) (1984) 0.83
Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. Biochim Biophys Acta (1989) 0.82
Microvascular alterations in chronically streptozotocin-diabetic rats. Adv Metab Disord (1973) 0.82
[Glucose metabolism in fatty tissue and muscle of animals with metabolic obesity or obesity due to overeating]. Acta Clin Belg (1968) 0.82
HDL lipids in close relatives of coronary heart disease patients. Environmental and genetic influences. Atherosclerosis (1979) 0.81
Liver glycerokinase deficiency in man with hyperglycerolaemia and hypertriglyceridaemia. Eur J Clin Invest (1984) 0.81
HDL particle associated proteins in plasma and cerebrospinal fluid: identification and partial sequencing. Appl Theor Electrophor (1988) 0.81
Validation of a tracer technique to determine nonsteady-state ketone body turnover rates in man. Am J Physiol (1981) 0.81
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications. Biochim Biophys Acta (1991) 0.81
Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic haemochromatosis. Eur J Clin Invest (1973) 0.81
Glucose transport in isolated fat cells. Procedures for measurement of the intracellular water space. Helv Physiol Pharmacol Acta (1966) 0.80
Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. Atherosclerosis (1990) 0.80
Metabolic effects of dietary fiber from dehulled soybeans in humans. Am J Clin Nutr (1983) 0.80
Fatty acid-independent inhibition of hepatic ketone body production by insulin in humans. Am J Physiol (1988) 0.79
Ultrastructural changes in A-cells exposed to diabetic hyperglycaemia. Observations made on pancreas of Chinese hamsters. Diabetologia (1970) 0.79
[Apoprotein E (apo E) phenotype and serum lipids in diabetics]. Schweiz Med Wochenschr (1987) 0.79
Differential effect of ouabain on glucose-induced biphasic insulin release in vitro. Am J Physiol (1971) 0.79
Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms. Clin Chim Acta (1994) 0.78
Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII. J Lipid Res (1994) 0.78
Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care (1995) 0.78
The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 0.78
[Spontaneous diabetes in animals. Considerations of the pathogenesis of acute syndrome and on the morphology of lesions of chronic syndrome]. Pathol Biol (Paris) (1970) 0.78
Comparative studies of muscle and adipose tissue metabolism in lean and obese mice. Ann N Y Acad Sci (1965) 0.78
An apparent abnormaltiy of the B-cell microtubular system in spiny mice (Acomys cahirinus). Diabetologia (1975) 0.78
Contribution of alpha- and beta-receptors to ketogenic and lipolytic effects of norepinephrine in humans. Diabetes (1989) 0.78
Comparative study of early metabolic events resulting from the administration of the two diabetogenic agents alloxan and streptozotocin. Eur J Clin Invest (1970) 0.78
Failure of glucagon to stimulate ketone body production during acute insulin deficiency or insulin replacement in man. Diabetologia (1982) 0.78
High density lipoprotein cholesterol in male relatives of patients with coronary heart disease. Atherosclerosis (1979) 0.78
Effect of acute acidosis and alkalosis on leucine kinetics in man. Clin Physiol (1992) 0.78
Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. Atherosclerosis (1986) 0.77
Acquired (secondary) forms of hypertriglyceridemia. Am J Cardiol (1991) 0.77
Glycogenosomes in renal tubular cells of diabetic animals. J Ultrastruct Res (1971) 0.77
Micro gel electrophoresis modification for dilute (protein) solutions. Anal Biochem (1970) 0.77
The metabolic response of lean and obese mice to prolonged fasting. Horm Metab Res (1974) 0.77
Factors influencing the low density lipoprotein profile in type 2 diabetic patients. Diabet Med (1995) 0.77
Underexpression of the apolipoprotein E4 isoform in an Italian population. Arterioscler Thromb (1993) 0.77
Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms. J Clin Invest (1989) 0.77
HDL and coronary heart disease: a familial trend. Adv Exp Med Biol (1987) 0.77
[The effect of salmon calcitonin on pancreatic enzymes and hormones before and after retrograde cholangiopancreatography]. Schweiz Med Wochenschr (1981) 0.77
Decreased HDL cholesterol in prepubertal and pubertal children of CHD patients. Atherosclerosis (1980) 0.76
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
HDL cholesterol levels in patients with myocardial infarction and their families. Atherosclerosis (1986) 0.76
Experimental and spontaneous diabetes in animals: what is their relevance to human diabetes mellitus? Proc R Soc Med (1971) 0.75
Human ketone body production and utilization studied using tracer techniques: regulation by free fatty acids, insulin, catecholamines, and thyroid hormones. Diabetes Metab Rev (1989) 0.75
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency. Eur J Pediatr (1997) 0.75
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am J Ophthalmol (1994) 0.75
[Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners]. Ther Umsch (1970) 0.75
[Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions]. Helv Med Acta (1967) 0.75
[Prediabetes and early diabetes]. Pol Tyg Lek (1966) 0.75
[25 years allogenic bone marrow transplantation in Basel: 1973-1998]. Schweiz Med Wochenschr (1998) 0.75
[Vascular complications of diabetes]. Ther Umsch (1967) 0.75
[Diabetic retinopathy: study on the action of l'o-beta-hydroxyethylrutoside for retinal fluoresceinography]. Helv Med Acta Suppl (1969) 0.75
[Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions]. Helv Med Acta Suppl (1967) 0.75
Diabetic retinopathy: study of the action of O-betahydroxyethyl-rutosides (HR) by retinal fluoresceinography. Diabetologia (1970) 0.75
Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data. Helv Med Acta (1967) 0.75